SKI Market

A+| A| A-|

Indian Indices

Sensex

77,017.79 -251.61
( -0.33%)

Global Indices

Nasdaq

48,970.60 -549.68
(-1.11%)

Dow Jones

7,222.65 -28.47
(-0.39%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,219.44 -144.49
(-1.39%)

Forex

USD-INR

94.82 -0.13
(-0.14%)

EUR-INR

111.15 0.04
(0.04%)

GBP-INR

128.70 0.21
(0.16%)

JPY-INR

0.60 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.53

107826.86

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.2

Back

Cipla consolidated net profit declines 56.97% in the December 2025 quarter

Jan 23,2026

Net profit of Cipla declined 56.97% to Rs 675.80 crore in the quarter ended December 2025 as against Rs 1570.51 crore during the previous quarter ended December 2024. Sales rose 0.02% to Rs 6962.97 crore in the quarter ended December 2025 as against Rs 6961.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	6962.97	6961.60	0
OPM %	18.02	28.57	-
PBDT	1447.37	2195.89	-34
PBT	1169.02	1916.09	-39
NP	675.80	1570.51	-57

77,017.79 -251.61 ( -0.33%)

48,970.60 -549.68 (-1.11%)

7,222.65 -28.47 (-0.39%)

59,594.47 309.55 (0.52%)

10,219.44 -144.49 (-1.39%)

94.82 -0.13 (-0.14%)

111.15 0.04 (0.04%)

128.70 0.21 (0.16%)

0.60 0.00 (0.59%)